Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

How to Earn $500 a Month From Dow Stock Ahead of Q2 Earnings

by Avi Kapoor | Jul 22, 2026 | General

Dow Inc. (NYSE:DOW) will release earnings for its second quarter before the opening bell on Thursday, July 23. Analysts expect the company to report quarterly earnings of $1.28 per share, versus a loss of 42 cents per share in the year-ago period. The consensus...

Google Parent Alphabet Stock Sits Below Key Averages Ahead of Earnings Report

by Dylan Berman | Jul 22, 2026 | General

Alphabet Inc. (NASDAQ:GOOG) shares are in the spotlight, with earnings on deck, a mixed technical setup and Edge Rankings all drawing attention. Alphabet stock is trading near recent highs. What’s the outlook for GOOG shares? Earnings Preview & History Alphabet is...

After Argentina, Pakistan Reportedly Seeks $10 Billion US Backstop Facility to Bolster Fragile Economy

by Namrata Sen | Jul 22, 2026 | General

In a bid to strengthen its economy, Pakistan has reportedly sought a $10 billion exchange stabilization facility from the United States. Following its diplomatic role in the Iran war negotiations, Pakistan’s international standing has seen a boost, sparking hopes of...
Pete Hegseth Torched By Gary Peters in Fierce Showdown as Senator Says Pentagon Chief Has ‘No Strategy’ and ‘No Long-Term Plan’ to Win Iran War

Pete Hegseth Torched By Gary Peters in Fierce Showdown as Senator Says Pentagon Chief Has ‘No Strategy’ and ‘No Long-Term Plan’ to Win Iran War

by Shomik Sen Bhattacharjee | Jul 22, 2026 | General

Sen. Gary Peters (D-Mich.) branded Defense Secretary Pete Hegseth a “failure” on Tuesday, accusing him of having “no strategy” and “no long-term plan” to win the war against Iran while seeking nearly $70 billion more from Congress....

Celldex Treatment Fails To Relieve Chronic Itch, Abandons Prurigo Nodularis Study

by Vandana Singh | Jul 22, 2026 | General

Celldex Therapeutics Inc. (NASDAQ:CLDX) on Tuesday said it is ending its Phase 2 clinical trial evaluating barzolvolimab for prurigo nodularis, a chronic condition characterized by intensely itchy skin nodules. The discontinuation comes after the study failed to...
« Older Entries
Next Entries »

Recent Posts

  • Bitcoin, Ethereum, XRP, Dogecoin Flat Despite Crypto Bill Getting Ethics Provisions: Analyst Highlights Level to ‘Watch’ for BTC
  • Google-Parent Alphabet, Tesla, ServiceNow, IBM and Texas Instruments: Why These 5 Stocks are on Investors’ Radars Today
  • Here’s How Much You Would Have Made Owning Lockheed Martin Stock In The Last 15 Years
  • Transcript: Cathay General Q2 2026 Earnings Conference Call
  • Here’s How Much You Would Have Made Owning iShares Russell 1000 Growth Fund Stock In The Last 10 Years

Recent Comments

    Archives

    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.